ArticleBMC complementary medicine and therapies2025

Exploring the potential of Gonolobus condurango as a histone deacetylase inhibitor in triple-negative breast cancer cell lines: in vitro study.

Beate Vajen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.